Referanslar

1. Kurtz SM, Lau E, Schmier J, et al. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty. 2008;23(7):984-991. [Crossref]  [PubMed]
2. Soohoo NF, Farng E, Lieberman JR, Chambers L, Zingmond DS. Factors that predict short-term complication rates after total hip arthroplasty. Clin Orthop Relat Res. 2010;468(9):2363-2371 [Crossref]  [PubMed]  [PMC]
3. Ridgeway S, Wilson J, Charlet A, Kafatos G, Pearson A, Coello R. Infection of the surgical site after arthroplasty of the hip. J. Bone Joint Surg. Br. 2005;87(6):844-850. [Crossref]  [PubMed]
4. Dale H, Skråmm I, Løwer HL, et al. Infection after primary hip arthroplasty: a comparison of 3 Norwegian health registers. Acta Orthop. 2011;82(6):646-654. [Crossref]  [PubMed]  [PMC]
5. Cordero-Ampuero J, Esteban J, García-Rey E. Results after late polymicrobial, gram-negative, and methicillin-resistant infections in knee arthroplasty. Clin Orthop Relat Res. 2010;468(5):1229-1236. [Crossref]  [PubMed]  [PMC]
6. Jämsen E, Nevalainen P, Kalliovalkama J, Moilanen T. Preoperative hyperglycemia predicts infected total knee replacement. Eur J Intern Med. 2010;21(3): 196-201. [Crossref]  [PubMed]
7. Kim M-K, Patel RA, Shinn AH, et al. Evaluation of gender difference in skin type and pH. J Dermatol Sci. 2006;41(2):153-156. [Crossref]  [PubMed]
8. Herwaldt LA, Cullen JJ, French P, et al. Preoperative risk factors for nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol. 2004;25(6): 481-484. [Crossref]  [PubMed]
9. SooHoo NF, Lieberman JR, Ko CY, Zingmond DS. Factors predicting complication rates following total knee replacement. J Bone Joint Surg Am. 2006;88(3):480-485. [Crossref]  [PubMed]
10. Kurtz SM, Ong KL, Lau E, Bozic KJ, Berry D, Parvizi J. Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res. 2010 Jan;468(1):52-56. [Crossref]  [PubMed]  [PMC]
11. Gandhi R, Razak F, Davey JR, Mahomed NN. Metabolic syndrome and the functional outcomes of hip and knee arthroplasty. J Rheumatol. 2010;37(9):1917-1922. [Crossref]  [PubMed]
12. Namba RS, Paxton L, Fithian DC, Stone ML. Obesity and perioperative morbidity in total hip and total knee arthroplasty patients. J Arthroplasty. 2005;20 Suppl 3:46-50. [Crossref]  [PubMed]
13. Malinzak RA, Ritter MA, Berend ME, et al. Morbidly obese, diabetic, younger, and unilateral joint arthroplasty patients have elevated total joint arthroplasty infection rates. J Arthroplasty. 2009;24(6 Suppl):84-88. [Crossref]  [PubMed]
14. Winiarsky R, Barth P, Lotke P. Total knee arthro plasty in morbidly obese patients. J Bone Joint Surg Am. 1998;80(12):1770-1774. [Crossref]  [PubMed]
15. Patel VP, Walsh M, Sehgal B, et al. Factors associ ated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am. 2007;89(1):33-38. [Crossref]  [PubMed]
16. Hopf HW, Hunt TK, West JM, et al. Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. Arch Surg. 1997;132(9):997-1004. [Crossref]  [PubMed]
17. Pozzilli P, Leslie RD. Infections and diabetes: mechanisms and prospects for prevention. Diabet Med. 1994;11(10):935-41. [Crossref]  [PubMed]
18. Moucha CS, Clyburn T, Evans RP, Prokuski L. Modifi able risk factors for surgical site infection. J Bone Joint Surg Am. 2011;93(4):398-404. [PubMed]
19. Dowsey MM, Choong PFM. Obesity is a major risk factor for prosthetic infection after primary hip arthroplasty. Clin Orthop Relat Res. 2008;466(1): 153-158. [Crossref]  [PubMed]  [PMC]
20. Jorgensen LN, Kallehave F, Christensen E, Siana JE, Gottrup F. Less collagen production in smokers. Surgery. 1998;123(4):450-455. [Crossref]  [PubMed]
21. Sørensen LT, Jørgensen S, Petersen LJ, et al. Acute effects of nicotine and smoking on blood fl ow, tissue oxygen, and aerobe metabolism of the skin and sub cutis. J Surg Res. 2009;152(2):224-230. [Crossref]  [PubMed]
22. Møller AM, Villebro N, Pedersen T, Tønnesen H. Effect of preoperative smoking intervention on post operative complications: a randomised clinical trial. Lancet. 2002;359(9301):114-117. [Crossref]  [PubMed]
23. Dowsey MM, Choong PFM. Obese diabetic patients are at substantial risk for deep infection after pri mary TKA. Clin Orthop Relat Res. 2009;467(6):1577-1581. [Crossref]  [PubMed]  [PMC]
24. Peersman G, Laskin R, Davis J, Peterson M. Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res. 2001;392:15-23. [Crossref]  [PubMed]
25. Lai K, Bohm ER, Burnell C, Hedden DR. Presence of medical comorbidities in patients with infected primary hip or knee arthroplasties. J Arthroplasty. 2007;22(5):651-656. [Crossref]  [PubMed]
26. De Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol. 2003;56(3): 221-229. [Crossref]  [PubMed]
27. Culver DH, Horan TC, Gaynes RP, et al. Surgical wound infection rates by wound class, operative pro cedure, and patient risk index. National Nosocomial Infections Surveil- lance System. Am J Med. 1991;91(3B):152S-157S. [Crossref]  [PubMed]
28. Berbari EF, Hanssen AD, Duffy MC, et al. Risk fac tors for prosthetic joint infection: case-control study. Clin Infect Dis. 1998;27(5):1247-1254. [Crossref]  [PubMed]
29. Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population- based study. Arthritis Rheum. 2002;46(9):2287-2293. [Crossref]  [PubMed]
30. White RH, McCurdy SA, Marder RA. Early morbid ity after total hip replacement: rheumatoid arthritis versus osteoarthritis. J Gen Intern Med. 1990;5(4): 304-309. [Crossref]  [PubMed]
31. Bassetti S, Wasmer S, Hasler P, et al. Staphylococcus aureus in patients with rheumatoid arthritis under conventional and anti-tumor necrosis factor-alpha treatment. J Rheumatol. 2005;32(11):2125-2129. [PubMed]
32. Howe CR, Gardner GC, Kadel NJ. Perioperative medication management for the patient with rheu matoid arthritis. J Am Acad Orthop Surg. 2006;14(9):544-551. [Crossref]  [PubMed]
33. Grennan D, Gray J, Loudon J, Fear S. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective ortho paedic surgery. Ann Rheum Dis. 2001;60(3):214-217. [Crossref]  [PubMed]  [PMC]
34. Momohara S, Kawakami K, Iwamoto T, et al. Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs. Mod Rheu- matol. 2011;21(5): 469-475. [Crossref]  [PubMed]
35. Bongartz T, Sutton AJ, Sweeting MJ, et al. Anti- TNF anti- body therapy in rheumatoid arthritis and the risk of serious infections and malignancies. JAMA. 2006;295(19):2275- 2285. [Crossref]  [PubMed]
36. Zintzaras E, Dahabreh IJ, Giannouli S, Voulgarelis M, Moutsopoulos HM. Infl iximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens. Clin Ther. 2008;30(11):1939- 1955. [Crossref]  [PubMed]
37. Dronge AS, Perkal MF, Kancir S, et al. Long-term glycemic control and postoperative infectious com plications. Arch Surg. 2006;141(4):375-380 [Crossref]  [PubMed]
38. Meding JB, Reddleman K, Keating ME, et al. Total knee replacement in patients with diabetes mellitus. Clin Orthop Relat Res. 2003;416:208-216. [Crossref]  [PubMed]
39. Mraovic B, Suh D, Jacovides C, Parvizi J. Perioperative hyperglycemia and postoperative infection after lower limb arthroplasty. J Diabetes Sci Technol. 2011;5(2):412-418. [Crossref]  [PubMed]  [PMC]
40. Anon. Intensive blood-glucose control with sulpho nylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837-853. [Crossref]  [PubMed]
41. Iorio R, Williams KM, Marcantonio AJ, Specht LM, Tilzey JF, Healy WL. Diabetes mellitus, hemoglobin A1C, and the incidence of total joint arthroplasty infection. J Arthroplasty. 2012;27(5):726-9.e1. [Crossref]  [PubMed]
42. Bozic KJ, Lau E, Kurtz S, Ong K, Berry DJ. Patient-related risk factors for postoperative mortality and periprosthetic joint infection in medicare patients undergoing TKA. Clin Orthop Relat Res. 2012;470(1):130-137. [Crossref]  [PubMed]  [PMC]
43. Liddle AD, Abram S, Iyer S, Andrade AJ. Streptococcus gallolyticus prosthetic joint infection associated with undiagnosed colonic malignancy. Knee Surg Sports Traumatol Arthrosc. 2012;20(6): 1069-1070. [Crossref]  [PubMed]
44. Hernigou P, Zilber S, Filippini P, et al. Total THA in adult osteonecrosis related to sickle cell disease. Clin Orthop Relat Res. 2008;466(2):300-308. [Crossref]  [PubMed]  [PMC]
45. Acurio MT, Friedman RJ. Hip arthroplasty in patients with sickle-cell haemoglobinopathy. J Bone Joint Surg Br. 1992;74(3):367-371. [Crossref]  [PubMed]
46. Ilyas I, Moreau P. Simultaneous bilateral total hip arthroplasty in sickle cell disease. J Arthroplasty. 2002;17(4):441-445. [Crossref]  [PubMed]
47. Silva M, Luck Jr JV. Long-term results of primary total knee replacement in patients with hemophilia. J Bone Joint Surg Am. 2005;87(1):85-91. [Crossref]  [PubMed]
48. Galat DD, McGovern SC, Hanssen AD, et al. Early return to surgery for evacuation of a postoperative hematoma after primary total knee arthroplasty. J Bone Joint Surg Am. 2008;90(11):2331-2336. [Crossref]  [PubMed]
49. Goddard NJ, Mann HA, Lee CA. Total knee replace ment in patients with end-stage haemophilic arthrop athy: 25-year results. J Bone Joint Surg Br. 2010;92(8):1085-1089. [Crossref]  [PubMed]
50. Norian JM, Ries MD, Karp S, Hambleton J. Total knee arthroplasty in hemophilic arthropathy. J Bone Joint Surg Am. 2002;84-A(7):1138-1141. [Crossref]  [PubMed]
51. Greene KA, Wilde AH, Stulberg BN. Preoperative nutritional status of total joint patients. Relationship to postoperative wound complications. J Arthroplasty. 1991;6(4):321-325. [Crossref]  [PubMed]
52. Jaberi FM, Parvizi J, Haytmanek CT, Joshi A, Purtill J. Procrastination of wound drainage and malnutri tion affect the outcome of joint arthroplasty. Clin Orthop Relat Res. 2008;466(6):1368-1371. [Crossref]  [PubMed]  [PMC]
53. Bozic KJ, Lau E, Kurtz S, et al. Patient-related risk factors for periprosthetic joint infection and postop erative mortality following total hip arthroplasty in medicare patients. J Bone Joint Surg Am. 2012;94(9): 794-800. [Crossref]  [PubMed]
54. Jämsen E, Huhtala H, Puolakka T, Moilanen T. Risk factors for infection after knee arthroplasty. A register- based analysis of 43,149 cases. J Bone Joint Surg Am. 2009;91(1):38-47. [Crossref]  [PubMed]
55. Suzuki G, Saito S, Ishii T, et al. Previous fracture surgery is a major risk factor of infection after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2011;19(12):2040- 2044. [Crossref]  [PubMed]
56. Blasco-Colmenares E, Perl TM, Guallar E, et al. Aspirin plus clopidogrel and risk of infection after coronary artery bypass surgery. Arch Intern Med. 2009;169(8):788-796. [Crossref]  [PubMed]
57. Nandi S, Aghazadeh M, Talmo C, Robbins C, Bono J. Perioperative clopidogrel and postoperative events after hip and knee arthroplasties. Clin Orthop Relat Res. 2012;470(5):1436-1441. [Crossref]  [PubMed]  [PMC]
58. Parvizi J, Ghanem E, Joshi A, et al. Does "exces sive" anti- coagulation predispose to periprosthetic infection? J Arthroplasty. 2007;22(6 Suppl 2):24-28. [Crossref]  [PubMed]
59. Stern SH, Wixson RL, O'Connor D. Evaluation of the safety and effi cacy of enoxaparin and warfarin for prevention of deep vein thrombosis after total knee arthroplasty. J Arthroplasty. 2000;15(2):153-158. [Crossref]  [PubMed]
60. Fitzgerald RH, Spiro TE, Trowbridge AA, et al. Prevention of venous thromboembolic disease fol lowing primary total knee arthroplasty. A random ized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin. J Bone Joint Surg Am. 2001;83-A(6):900-906. [Crossref]  [PubMed]
61. Sachs RA, Smith JH, Kuney M, Paxton L. Does anti coagulation do more harm than good?: A comparison of patients treated without prophylaxis and patients treated with low-dose warfarin after total knee arthro plasty. J Arthroplasty. 2003;18(4):389-395. [Crossref]  [PubMed]
62. Wilson MG, Kelley K, Thornhill TS. Infection as a complication of total knee-replacement arthroplasty. Risk factors and treatment in sixty-seven cases. J Bone Joint Surg Am. 1990;72(6):878-883. [Crossref]  [PubMed]
63. Kluytmans J, Van Belkum A, Verbrugh H. Nasal car riage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10(3):505-520. [Crossref]  [PubMed]  [PMC]
64. Shuter J, Hatcher VB, Lowy FD. Staphylococcus aureus binding to human nasal mucin. Infect Immun. 1996;64(1):310-318. [Crossref]  [PubMed]  [PMC]
65. Bozic KJ, Maselli J, Pekow PS, et al. The infl uence of procedure volumes and standardization of care on quality and effi ciency in total joint replacement sur gery. J Bone Joint Surg Am. 2010;92(16):2643-2652. [Crossref]  [PubMed]
66. Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Peripros- thetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res. 2008;466(7):1710-1715. [Crossref]  [PubMed]  [PMC]
67. Katz JN, Losina E, Barrett J, et al. Association between hospital and surgeon procedure volume and outcomes of total hip replacement in the united states medicare population*. J Bone Joint Surg Am. 2001;83(11):1622-1629. [Crossref]  [PubMed]
68. Willis-Owen CA, Konyves A, Martin DK. Factors affecting the incidence of infection in hip and knee replacement: an analysis of 5277 cases. J Bone Joint Surg Br. 2010;92(8):1128-1133. [Crossref]  [PubMed]
69. Poss R, Thornhill TS, Ewald FC, et al. Factors infl u encing the incidence and outcome of infection fol lowing total joint arthroplasty. Clin Orthop Relat Res. 1984;182:117-126. [Crossref]  [PubMed]
70. Blom AW, Brown J, Taylor AH, et al. Infection after total knee arthroplasty. J Bone Joint Surg Br. 2004;86(5):688- 691. [Crossref]  [PubMed]
71. Ahnfelt L, Herberts P, Malchau H, Andersson GB. Prognosis of total hip replacement. A Swedish multicenter study of 4,664 revisions. Acta Orthop Scand Suppl. 1990;238:1-26. [Crossref]  [PubMed]
72. Urquhart DM, Hanna FS, Brennan SL, et al. Incidence and risk factors for deep surgical site infection after primary total hip arthroplasty: a sys tematic review. J Arthroplasty. 2010;25(8):1216-1222.e1-3. [Crossref]  [PubMed]
73. Leong G, Wilson J, Charlett A. Duration of opera tion as a risk factor for surgical site infection: com parison of English and US data. J Hosp Infect. 2006;63(3):255-262. [Crossref]  [PubMed]
74. Namdari S, Voleti PB, Baldwin KD, Lee G-C. Primary total joint arthroplasty performed in operat ing rooms following cases of known infection. Orthopedics. 2011;34(9):e541-545. [Crossref]  [PubMed]
75. Mauermann WJ, Nemergut EC. The anesthesiolo gist's role in the prevention of surgical site infections. Anesthesiology. 2006;105(2):413-21; quiz 439-440. [Crossref]  [PubMed]
76. Pedersen AB, Svendsson JE, Johnsen SP, Riis A, Overgaard S. Risk factors for revision due to infec tion after primary total hip arthroplasty. A population- based study of 80,756 primary proce dures in the Danish Hip Arthroplasty Registry. Acta Orthop. 2010;81(5):542-547. [Crossref]  [PubMed]  [PMC]
77. Chang C-C, Lin H-C, Lin H-W, Lin H-C. Anesthetic management and surgical site infections in total hip or knee replacement: a population-based study. Anesthesiolo- gy. 2010;113(2):279-284. [Crossref]  [PubMed]
78. Saleh K, Olson M, Resig S, et al. Predictors of wound infection in hip and knee joint replacement: results from a 20 year surveillance program. J Orthop Res. 2002;20(3):506-515. [Crossref]  [PubMed]
79. Ekkelenkamp MB, Van der Bruggen T, Van de Vijver DAMC, Wolfs TFW, Bonten MJM. Bacteremic complications of intravascular catheters colonized with Staphylococcus aureus. Clin Infect Dis. 2008;46(1):114-118. [Crossref]  [PubMed]
80. Murdoch DR, Roberts SA, Fowler Jr VG, et al. Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. Clin Infect Dis. 2001;32(4):647-649. [Crossref]  [PubMed]
81. Sendi P, Banderet F, Graber P, Zimmerli W. Periprosthetic joint infection following Staphy lococcus aureus bacteremia. J Infect. 2011;63(1): 17-22. [Crossref]  [PubMed]
82. Raghavan M, Marik PE. Anemia, allogenic blood transfusion, and immunomodulation in the critically ill. Chest. 2005;127(1):295-307. [Crossref]  [PubMed]
83. Katz JN, Barrett J, Mahomed NN, et al. Association between hospital and surgeon procedure volume and the outcomes of total knee replacement. J Bone Joint Surg Am. 2004;86(9):1909-1916. [Crossref]  [PubMed]
84. Berbari EF, Osmon DR, Carr A, Hanssen AD, Baddour LM, Greene D, Kupp LI, Baughan LW, Harmsen WS, Mandrekar JN, Therneau TM, Steckelberg JM, Virk A, Wilson WR. Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin Infect Dis. 2010 1;50(1):8-16 [Crossref]  [PubMed]
85. Waldman BJ, Mont MA, Hungerford DS. Total knee arthroplasty infections associated with dental proce dures. Clin Orthop Relat Res. 1997;343:164-172. [Crossref]  [PubMed]
86. LaPorte DM, Waldman BJ, Mont MA, Hungerford DS. Infections associated with dental procedures in total hip ar- throplasty. J Bone Joint Surg Br. 1999;81(1):56-59. [Crossref]  [PubMed]
87. Zimmerli W, Sendi P. Antibiotics for prevention of periprosthetic joint infection following dentistry: time to focus on data. Clin Infect Dis. 2010;50(1): 17-19. [Crossref]  [PubMed]
88. Hu J, Liu Y, Lv Z, et al. Mortality and morbidity associated with simultaneous bilateral or staged bilateral total knee arthroplasty: a meta-analysis. Arch Orthop Trauma Surg. 2011;131(9):1291-1298. [Crossref]  [PubMed]